Abstract
Background
Postoperative rectovaginal fistula leads to a loss of patients’ quality of life and presents significant challenges to the surgeon. The literature focusing specifically on postoperative rectovaginal fistulas is limited. The objective of the present study is to identify factors that can enhance the success of the management of this postoperative rectovaginal fistula.
Methods
This retrospective multicentric study included all patients undergoing surgery for rectovaginal fistulas, excluding those for whom the etiology of rectovaginal fistula was not postoperative. The major outcome measure was the success of the procedure.
Results
A total of 82 patients with postsurgical fistulas were identified, of whom 70 were successfully treated, giving a success rate of 85.4%. On average, these patients required 3.04 ± 2.72 interventions. The creation of a diversion stoma did not increase the success rate of management [odds ratio (OR) = 0.488; 95% confidence interval (CI) 0.107–2.220]. Among the 217 procedures performed, 69 were successful, accounting for a 31.8% success rate. The number of interventions and the creation of a diversion stoma did not correlate with the success of management. However, direct coloanal anastomosis was significantly associated with success (OR = 35.06; 95% CI 1.271–997.603; p = 0.036) as compared with endorectal advancement flap (ERAF). Other procedures such as Martius flap did not show a significantly higher success rate.
Conclusion
The creation of a diversion stoma is not necessary in closing a fistula. ERAF should be considered as a first-line treatment prior to proposing more invasive approach such as direct coloanal anastomosis.
Avoid common mistakes on your manuscript.
Mini-invasive surgery such as endorectal advancement flap should be proposed as the first approach to treat postoperative rectovaginal fistula, with a success rate of near 30% prior proposing a more invasive surgery (coloanal or colorectal anastomosis). Diverting stoma is not mandatory in such situation. |
Introduction
Rectovaginal fistula (RVF) is defined as an abnormal communication between the rectum and the vagina through the rectovaginal septum. It is characterized by the passage of rectal contents (gas and/or feces) into the vagina. Rectovaginal fistulas account for approximately 5% of all anorectal fistulas, which have an incidence in Europe ranging from 1.20 to 2.80 per 10,000 people each year [1, 2]. Acquired rectovaginal fistulas have numerous etiologies, including inflammatory, obstetrical, and postoperative causes [3, 4]. These fistulas significantly impact the quality of life (social, sports, etc.) of affected patients and lead to a deterioration in their emotional well-being [5, 6].
To the best of our knowledge, there are no specific recommendations for the surgical management of RVF. Indeed, research published to date largely focuses on the management of rectovaginal fistulas without considering their etiology, even though it has been demonstrated that the etiology of fistulas plays an important role in determining the success rate of fistula closures [7, 8]. Moreover, although the literature on postoperative rectovaginal fistulas is scarce, their incidence ranges from 0.58% to 5.1% depending on the performed intervention [9, 10].
Numerous surgical techniques have described, all with varying degrees of success. These include endoscopic techniques, more or less invasive surgical procedures involving the use of flaps (vaginal, mesorectal, peritoneal, muscular), autologous buccal mucosa grafts, or platelet-rich plasma [3, 11,12,13,14,15,16,17,18,19,20,21,22]. To date, no technique has succeeded in establishing itself as the standard treatment for postoperative rectovaginal fistulas. The lack of standardization in treatment is even more problematic because the repair of rectovaginal fistulas resulted in complications in 13.2% of cases, with 7.9% of all complications being serious [23].
The aim of this study was to provide new insights into postoperative rectovaginal fistulas and their management.
Materials and methods
We conducted a retrospective multicenter cohort study including all patients referred for surgical treatment for postoperative rectovaginal fistulas according to a database performed across 10 centers for all the patients undergoing surgery for RVF. A previous study using this database only included patients whose fistula was secondary to an obstetrical anal sphincter injury (OASI) [24].
To be included in the present analysis, the patients needed to have undergone surgery for RVF secondary to proctological, gynecological, or colorectal surgery between 2005 and 2020. Patients were excluded if the fistula was not secondary to a surgical procedure [e.g., RVF due to AOSI, traumatic RVF and RVF due to Crohn’s disease (CD)] if no surgical procedure had been performed to close the fistula, if a terminal or diverting stoma had not been created without a repair procedure, or if the patient had expressed his or her opposition to participating in retrospective studies. If patients with CD experienced a RVF after any surgery for any other cause, they could be included in this study.
The study received the approval of our local ethics committee (2021/034) and the database was declared to the Commission National Informatique et Libertés (France’s national data protection agency) (ar21-0014v0).
Patients were selected according to the reason why they had been admitted to hospital25. The following data were collected in an anonymized database:
-
Demographic data: age, body mass index (BMI), medical history;
-
Surgical procedure that led to the fistula;
-
For each procedure performed to cure the fistula:
-
o
Type of surgery performed;
-
o
Creation of a diverting stoma;
-
o
Efficacy of the surgery;
-
o
-
Follow-up after the last surgery.
The main outcome measure was the success of the surgery, as clinically defined in the previous study, as the absence of stool or gas in the vagina [24]. If the patient had undergone a definitive stoma procedure to treat the suppuration, the management was not considered to have been successful.
Management of the patient
There was no standard perioperative management of the patients across the different centers [24]. All the centers involved were university hospitals that reported at least 30 cases of RVF each during the study period. The procedures and the order in which they were performed were left at the surgeon’s discretion. Sphincter-sparing procedures were primarily favored as recommended.
Statistical analysis
Continuous covariates were described using mean and standard deviations and compared using student tests, whereas categorical covariates were described using percentages and compared using chi-squared tests.
The relationship between the efficacy of surgery and the factors considered to be associated with it (e.g., diverting stoma, type of procedure, number of recurrences prior to the considered surgical treatment, BMI, and age of the patient) was assessed through a mixed logistic model considering patients as a random effect covariate. This enabled us to take into account the possible recurrences of the rectovaginal fistula among given patients.
In this model, the variance–covariance structure was defined as unstructured.
All statistical analyses were performed assuming a type I error probability of 0.05.
Results
A total of 332 patients with rectovaginal fistulas (RVF) were identified. Postoperative rectovaginal fistula was found in 105 (31.6%) (Fig. 1). Twenty-three patients were excluded because the primary endpoint was not available (n = 13) or because no repair procedure was performed (n = 10).
In the end, 82 patients with treated postoperative RVF were considered in this study. The mean age of these 82 patients was 48 years (± 17) and the mean BMI was 24.1 kg/m2 (± 5.1).
Among the 82 patients, a mean of 3 procedures (± 2.7) was performed per patient with no significant difference between the successful and unsuccessful groups (p = 0.08). A diverting stoma was performed in 60 patients (73.2%) during the course of the management. After the last intervention collected, 70 patients had a successful management of RVF (85.4%) (Table 1).
At baseline, there was no significant difference between the successful and unsuccessful groups of patients in terms of age, BMI, proctological history, parity, rectal cancer, and diverting stoma (Table 1). Patients were more likely to have a history of radiotherapy and/or Crohn's disease in the unsuccessful group (p = 0.02 and p = 0.04, respectively) (Table 1). In the cohort, 60 patients had a diverting stoma during the management (p = 0.39) ((Table 1). The initial surgeries performed were grouped into five categories, including gynecological surgeries, anterior rectal resections, surgeries for gynecological cancers, surgeries for rectocolitis (total coloproctecomy with ileoanal anastomosis), and proctological surgeries.
Description of surgery cohort
Out of the 82 patients, 217 interventions were performed, of which 69 procedures were successful (31.9%) and 137 (63.1%) were associated with the creation of a diverting stoma (Table 2). The presence of a diverting stoma was comparable in both the success and non-success arms (p = 0.66). The most frequently performed procedure was the endorectal advancement flap (44/217, i.e., 22.68% of all procedures) followed by the placement of a seton (22/117, 11.3%), and vaginal suture (22/217, 11.3%) (Table 2). More invasive procedures were performed in 8/217 (coloanal pull-through procedure), 5/217 (Soave procedure), 6/217 (direct coloanal anastomosis), and 11/217 cases (colorectal anastomosis).
Multivariate analysis of predictive factors of success.
In a multivariate analysis (Table 3), the creation of a diverting stoma did not increase the success rate of the overall management (OR = 0.71; 95% CI 0.12–4.29), as well as the number of interventions did not (OR = 0.90; 95% CI 0.71–1.16).
In another model of multivariate analysis aiming to assess the success of the procedure (Table 4), the creation of a diversion stoma did not increase the success rate of the success of the surgery (OR = 0.49; 95% CI 0.11–2.22), just as the number of surgical procedures performed had no effect on the success rate (OR = 1.09; 95% CI 0.81–1.48). Regarding the various surgical techniques employed, only direct coloanal or colorectal anastomosis showed a significant increase in the success of management as compared with the ERAF (OR = 35.60; 95% CI 1.27–997.60; p = 0.04).
Discussion
Out of the 82 patients with post-surgical RVF in our cohort, 70 were successfully treated, giving an overall success rate of 85.4%. On average, these patients required 3.04 ± 2.72 interventions. The creation of a diversion stoma did not increase the success rate of management (OR = 0.49; 95% CI 0.11–2.22). Among the 217 procedures performed, 69 were successful (31.8%). Performing a direct coloanal or colorectal anastomosis was significantly associated with success as compared with ERAF (OR = 35.06; 95% CI 1.27–997.60; p = 0.04). Other procedures did not show a significantly higher success rate.
Quite like in our cohort, the literature reports that RVF due to postoperative complications accounts for 6.3–40.2% of all cases of RVF [7, 25, 26]. Our study also reported that the surgical procedures that had caused RVF were predominantly anterior rectal resections (52.94%) and gynecological surgeries (27.94%). This is in line with the findings reported in the literature, notably by Drefs et al., who reported these procedures as caused RVF in 59.5% and 27.0% of cases, respectively [7]. Moreover, to the best of our knowledge, our cohort is the largest cohort of postoperative rectovaginal fistulas.
Our study found that creating a diversion stoma had no benefits with regard to improving the chances of fistula closure. There is no real consensus in literature on this point. Barugola et al. [27] found a higher success rate in the diversion stoma group (p value = 0.003) in a study of a cohort of 37 postoperative fistulas. Furthermore, Corte et al. [28] found an odds ratio of 3.5 (1.4–8.7) in favor of using a diversion stoma in a cohort of 79 RVF (including only 25 postoperative RVF). Then again, studies such as Fu et al. [29] and Lambertz et al. [30] found that creating a diversion stoma brought no benefit for patients, with respective p values of 0.490 and 0.603 and sample sizes of 63 and 62 RVF, including 18 and 15 postoperative ones. Abo-Alhassan F. et al. [31] found that stoma was associated with success rate in a cohort including multi-etiology RVF. Our study has the strength that it included only patients with postoperative RVF while all of the previous studies combined various etiologies of rectovaginal fistulas, irrespective of the fact that the success rate differs according to the etiology of the RVF. However, due to the retrospective nature of our study, it is important to consider that diversion stomas were probably more commonly performed in the most severe cases, thus potentially diminishing the effectiveness of diversion stomas and possibly representing a bias. Regarding the question of creating diversion stomas for postoperative rectovaginal fistulas, therefore, we agree with the conclusions of the German S3-Guidelines, recommended by Ommer et al. [32]: these state that creating diversion stomas should not be performed routinely, because there is no evidence to suggest that this represents the best treatment. That said, the decision to perform one should take into account the personal physical and psychological burden resulting from local inflammation and the extent of fistula secretion in cases of management failure.
Interestingly, our study highlights that direct coloanal or colorectal anastomosis may be much more successful than all of the other procedures that can be performed. Their superiority is also suggested, albeit backed up with only little evidence, in the literature. Karakayali et al. [33], for instance, demonstrate the benefits of coloanal anastomosis for radio-induced rectovaginal fistulas, showing no recurrence at 20 months and a significant improvement in quality of life. Additionally, Woo et al. [34] achieved a success rate of 85.7% with coloanal anastomosis for the treatment of rectovaginal fistulas secondary to anterior rectal resection. Surprisingly, the delayed coloanal anastomosis was not superior to ERAF nor direct coloanal or colorectal anastomosis. This may be explained by the fact that, while it might have appeared promising at first, delayed coloanal anastomosis had a success rate of only 68% [35]. However, because of a specific morbidity superior to the other procedures, in the context of RVF, coloanal or colorectal anastomosis may be proposed in second intention, especially in complicated cases.
Our study has a number of limitations, primarily being a retrospective study with the known shortcomings of this study type. We lacked details on perioperative management conditions, as shown by Hiraki et al. [36], where certain perioperative elements can improve treatment outcomes. Additionally, information on fistula characteristics (size, location, etc.) was lacking, while Lohsiriwat [37] demonstrated that therapeutic results are influenced by several factors, including the size and location of the fistula. Data regarding the incidence of diabetes and smoking, both of which could influence the success rate of healing, were also not collected, nor was information on which examinations were performed prior to surgery. Our study does not address operative morbidity or functional outcomes, especially in terms of anal continence, while such information could be of interest in informing physicians which procedure to choose. Finally, the initial procedures leading to the RVF were heterogeneous leading to a probable bias in the interpretation of the analysis of the procedures or of the need for a stoma. However, despite this heterogeneity, this cohort is one of the most homogeneous because it included only RVF secondary to pelvic surgery, while the other cohort study that focused on this subject included all causes of RVF.
Despite these limitations, this study provides evidence that a diverting stoma is by no means necessary in postoperative RVF, because it does not improve the rate of success. Instead, our findings suggest that, despite mitigated results, ERAF may be performed as a first-line treatment. Not only is this because ERAF has a low risk of morbidity, but also because the only procedure that showed a greater success rate while direct coloanal or colorectal anastomosis, has a higher risk of morbidity.
Conclusion
Our results suggest that creating a diverting stoma is not necessary in the management of postoperative RVF because it does not increase the success rate of the surgical procedures, nor of the overall management. An ERAF is effective in 1/3 cases and may be performed as first-line treatment intention before considering more morbid surgeries such as direct coloanal or colorectal.
Data availability
Data are available for reasonable request by addressing an e-mail to the corresponding author. No datasets were generated or analysed during the current study.
References
Tsang CB, Rothenberger DA (1997) Rectovaginal fistulas. Therapeutic options Surg Clin North Am 77:95–114
Zanotti C, Martinez-Puente C, Pascual I, Pascual M, Herreros D, García-Olmo D (2007) An assessment of the incidence of fistula-in-ano in four countries of the European Union. Int J Colorectal Dis 22:1459–1462
Zeng YX, He YH, Jiang Y, Jia F, Zhao ZT, Wang XF (2022) Minimally invasive endoscopic repair of rectovaginal fistula. World J Gastrointest Surg 14:1049–1059
Mudrov AA, Omarova MM, Fomenko OY, Blagodarnyi LA, Kostarev IV, Sokolova YA, Serebriy AB, Nagudov MA, Titov AY (2021) Surgical treatment of rectovaginal fistula with vaginal rectangular flap. Khirurgiia (Mosk) 7:5–11
Söderqvist EV, Cashin PH, Graf W (2022) Surgical treatment of rectovaginal fistula-predictors of outcome and effects on quality of life. Int J Colorectal Dis 37:1699–1707
Leroy A, Azaïs H, Giraudet G, Cosson M (2017) Évaluation de la qualité de vie et des symptômes avant et après prise en charge chirurgicale des fistules rectovaginales [Quality of life and symptoms before and after surgical treatment of rectovaginal fistula]. Prog Urol 27:229–237
Drefs M, Schömer Cuenca S, Wirth U, Kühn F, Burian M, Werner J, Zimmermann P (2023) Predictors of outcome for treatment of enterovaginal fistula : Therapeutical strategies for treatment. Int J Colorectal Dis 38(1):187
Karp NE, Kobernik EK, Berger MB, Low CM, Fenner DE (2019) Do the surgical outcomes of rectovaginal fistula repairs differ for obstetric and nonobstetric fistulas? A retrospective cohort study. Female Pelvic Med Reconstr Surg 25(1):36–40
Alborzi S, Roman H, Askary E, Poordast T, Shahraki MH, Alborzi S, Hesam Abadi AK, Najar Kolaii EH (2022) Colorectal endometriosis: Diagnosis, surgical strategies and post-operative complications. Front Surg 9:978326
Matthiessen P, Hansson L, Sjödahl R, Rutegård J (2010) Anastomotic-vaginal fistula (AVF) after anterior resection of the rectum for cancer–occurrence and risk factors. Colorectal Dis 12(4):351–357
Mudrov AA, Omarova MM, Fomenko OY, Blagodarnyi LA, Kostarev IV, Sokolova YA, Serebriy AB, Nagudov MA, Titov AY (2021) Khirurgicheskoe lechenie rektovaginal'nykh svishchei rasshcheplennym vlagalishchno-pryamokishechnym loskutom [Surgical treatment of rectovaginal fistula with vaginal rectangular flap]. Khirurgiia (Mosk) :5–11.
Hanacek J, Havluj L, Drahonovsky J, Urbankova I, Krepelka P, Feyereisl J (2019) Interposition of the mesorectal flap as prevention of rectovaginal fistula in patients with endometriosis. Int Urogynecol J 30:2195–2198
Boudy AS, Vesale E, Arfi A, Owen C, Jayot A, Zilberman S, Bendifallah S, Darai E (2020) Prevesical peritoneum interposition to prevent risk of rectovaginal fistula after en bloc colorectal resection with hysterectomy for endometriosis: results of a pilot study. J Gynecol Obstet Hum Reprod 49:101649
Kersting S, Athanasiadis CJ, Jung KP, Berg E (2019) Operative results, sexual function and quality of life after gracilis muscle transposition in complex rectovaginal fistulas. Colorectal Dis 21:1429–1437
Schwandner O, Falch C, Reisenauer C (2019) Erste ergebnisse der transperinealen ligatur des fisteltrakts bei rektovaginalen fisteln [Preliminary Results of Transperineal Ligation of Fistula Tract for Rectovaginal Fistulas]. Zentralbl Chir 144:374–379
Grimsby GM, Fischer AC, Baker LA (2014) Autologous buccal mucosa graft for repair of recurrent rectovaginal fistula. Pediatr Surg Int 30:533–535
Ouaïssi M, Cresti S, Giger U, Sielezneff I, Pirrò N, Berthet B, Grandval P, Consentino B, Sastre B (2010) Management of recto-vaginal fistulas after prosthetic reinforcement treatment for pelvic organ prolapse. World J Gastroenterol 16:3011–3015
Cui L, Chen D, Chen W, Jiang H (2009) Interposition of vital bulbocavernosus graft in the treatment of both simple and recurrent rectovaginal fistulas. Int J Colorectal Dis 24:1255–1259
Lee BH, Choe DH, Lee JH, Kim KH, Hwang DY, Park SY, Cho CK, Chin SY (1997) Device for occlusion of rectovaginal fistula: clinical trials. Radiology 203:65–69
Wise WE Jr, Aguilar PS, Padmanabhan A, Meesig DM, Arnold MW, Stewart WR (1991) Surgical treatment of low rectovaginal fistulas. Dis Colon Rectum 34:271–274
Pai V, Desouza A, De Menezes JL, Saklani A (2015) Rectovaginal fistula with anastomotic stricture post anterior resection - sphincter preservation, a viable option. Indian J Surg Oncol 6:256–258
Mongardini M, Iachetta RP, Cola A, Maturo A, Giofrè M, Custureri F (2009) Fistola retto-vaginale bassa post-radioterapia trattata con l’ausilio di PRP (gel piastrinico autologo) [Low rectovaginal fistula treated with platelet-rich plasma (PRP)]. G Chir 30(11–12):507–509
Chong W, Liu T, Bui A (2021) Incidence and risk factors for postoperative complications of rectovaginal fistula repairs, based on different surgical routes. Female Pelvic Med Reconstr Surg 27:e82–e90
Venara A, Trilling B, Ngoma M, Brochard C, Duchalais E, Siproudhis L, Faucheron JL, de Parades V, Alves A, Cotte E, Ouaissi M, Bridoux V, Corbière L, Heraud J Jr, Ortega-Deballon P, Abo-Alhassan F, Hamel JF (2022) Ano-rectovaginal fistula after obstetrical anal sphincter injury: Diverting stoma does not improve the surgical results. Colorectal Dis 24(11):1371–1378
Schlöricke E, Zimmermann M, Hoffmann M, Laubert T, Nolde J, Hildebrand P, Bruch HP, Bouchard R (2012) Chirurgische versorgung und prognose rektovaginaler fisteln in abhängigkeit ihrer genese [Surgical treatment and prognosis of rectovaginal fistulae according to their origin]. Zentralbl Chir 137(4):390–395
Soriano D, Lemoine A, Laplace C, Deval B, Dessolle L, Darai E, Poitout P (2001) Results of recto-vaginal fistula repair: retrospective analysis of 48 cases. Eur J Obstet Gynecol Reprod Biol 96(1):75–79
Barugola G, Bertocchi E, Leonardi A, Almoudaris AM, Ruffo G (2021) Post surgical rectovaginal fistula: who really benefits from stoma diversion? Updates Surg 73(1):165–171
Corte H, Maggiori L, Treton X, Lefevre JH, Ferron M, Panis Y (2015) Rectovaginal fistula: What is the optimal strategy?: An analysis of 79 patients undergoing 286 procedures. Ann Surg 262(5):855–860
Fu J, Liang Z, Zhu Y, Cui L, Chen W (2019) Surgical repair of rectovaginal fistulas: predictors of fistula closure. Int Urogynecol J 30(10):1659–1665
Lambertz A, Lüken B, Ulmer TF, Böhm G, Neumann UP, Klink CD, Krones CJ (2016) Influence of diversion stoma on surgical outcome and recurrence rates in patients with rectovaginal fistula - A retrospective cohort study. Int J Surg 25:114–117
Abo-Alhassan F, Trilling B, Sage PY, Tidadini F, Girard E, Faucheron JL (2023) Long-term outcomes of surgery for rectovaginal fistula in 100 consecutive patients at a tertiary center. J Gastrointest Surg 27(4):803–806
Ommer A, Herold A, Berg E, Fürst A, Schiedeck T, Sailer M (2012) German S3-Guideline: rectovaginal fistula. Ger Med Sci 10:Doc15.
Karakayali FY, Tezcaner T, Ozcelik U, Moray G (2016) The outcomes of ultralow anterior resection or an abdominoperineal pull-through resection and coloanal anastomosis for radiation-induced recto-vaginal fistula patients. J Gastrointest Surg 20(5):994–1001
Woo IT, Park JS, Choi GS, Park SY, Kim HJ, Lee HJ (2019) Optimal strategies of rectovaginal fistula after rectal cancer surgery. Ann Surg Treat Res 97(3):142–148
Collard MK, Rullier E, Tuech JJ, Sabbagh C, Souadka A, Loriau J, Faucheron JL, Benoist S, Dubois A, Dumont F, Germain A, Manceau G, Marchal F, Sourrouille I, Lakkis Z, Lelong B, Derieux S, Piessen G, Laforest A, Venara A, Prudhomme M, Brigand C, Duchalais E, Ouaissi M, Lebreton G, Rouanet P, Mège D, Pautrat K, Reynolds IS, Pocard M, Parc Y, Denost Q, Lefevre JH, GRECCAR group, (2023) Is Delaying a coloanal anastomosis the ideal solution for rectal surgery?: Analysis of a multicentric cohort of 564 patients from the GRECCAR. Ann Surg 278(5):781–789
Hiraki M, Tanaka T, Kanai T, Shimamura T, Ikeda O, Yasunaga M, Ogata S, Kitahara K (2020) The treatment for refractory rectovaginal fistula after low anterior resection with estriol, polyglycolic acid sheets and primary closure: A case report. Int J Surg Case Rep 75:483–487
Lohsiriwat V, Jitmungngan R (2021) Rectovaginal fistula after low anterior resection: prevention and management. World J Gastrointest Surg 13(8):764–771
Acknowledgements
None.
Funding
Open access funding provided by Université d'Angers.
Author information
Authors and Affiliations
Contributions
Conception: Aurélien Venara, Jean-Francois Hamel; Planning: Aurélien Venara, Jean-Francois Hamel, Bertrand Trilling; Execution: Aurélien Venara, Bertrand Trilling, Marie Ngoma, Charlène Brochard, Emilie Duchalais, Laurent Siproudhis, Jean-Luc Faucheron, Vincent de Parades, Arnaud Alves, Eddy Cotte, Mehdi Ouaissi, Valérie Bridoux, Lisa Corbière, Jeanne Heraud, Pablo Ortega-Deballon, Fawaz Abo-Alhassan, Jean-Francois Hamel; Analysis: Maëlig Poitevin, Aurélien Venara, Jean-Francois Hamel; Writing: Maëlig Poitevin, Aurélien Venara; Critical revision of manuscript for important intellectual content: Maëlig Poitevin, Aurélien Venara, Bertrand Trilling, Marie Ngoma, Charlène Brochard, Emilie Duchalais, Laurent Siproudhis, Jean-Luc Faucheron, Vincent de Parades, Arnaud Alves, Eddy Cotte, Mehdi Ouaissi, Valérie Bridoux, Lisa Corbière, Jeanne Heraud, Pablo Ortega-Deballon, Fawaz Abo-Alhassan, Jean-Francois Hamel; Final approval of the version to be published: Maëlig Poitevin, Aurélien Venara, Bertrand Trilling, Marie Ngoma, Charlène Brochard, Emilie Duchalais, Laurent Siproudhis, Jean-Luc Faucheron, Vincent de Parades, Arnaud Alves, Eddy Cotte, Mehdi Ouaissi, Valérie Bridoux, Lisa Corbière, Pablo Ortega-Deballon, Fawaz Abo-Alhassan, Jean-Francois Hamel.
Corresponding author
Ethics declarations
Conflict of interest
Venara declares potential conflicts of interest with Takeda, Coloplast, ThermoFisher, Biom'up, Sanofi-Aventis, to whom he provided consulting services and gave a lecture. The authors declare no competing interests. The other authors do not declare any conflicts of interest.
Ethical approval
The study received the approval of our local ethics committee (2021/034) and the database was declared to the Comission National Informatique et Libertés (ar21-0014v0). Patients were orally informed that their data could be used for retrospective studies. They were asked to inform the staff if they disagreed with the use of their data.
Informed consent
For this type of study, formal consent was not required. The patient was required to express his/her opposition for further use of his/her data.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Poitevin, M., Hamel, JF., Ngoma, M. et al. Postoperative rectovaginal fistula: stoma may not be necessary—a French retrospective cohort. Tech Coloproctol 28, 138 (2024). https://doi.org/10.1007/s10151-024-03013-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10151-024-03013-2